Two decimal places are retained because the source reports carry them and truncating would discard information where a laboratory genuinely reports it. The uncertainty budget on /methods/uncertainty-budget/ is the right thing to read alongside any purity figure on this site.
AX-2024-005364
GHRP-6 · 2 mg declared · PolyPeptide Group (Hangzhou) Co., Ltd. · lot PPG-2405-W6859
- Report ID
- AX-2024-005364
- Compound
- GHRP-6
- Compound class
- Growth-hormone axis peptides
- Supplier
- PPG — PolyPeptide Group (Hangzhou) Co., Ltd.
- Batch / lot
- PPG-2405-W6859
- Declared label claim
- 2mg
- Laboratory
- Medutest
- Assay date
- 11 Oct 2024
- Submitted
- 15 Oct 2024
- Quarter
- 2024-Q4
- Submitter
- Contributor #A-4471
- Sample provenance
- Buyer-sourced
Results
Measured against the index acceptance specification for the growth-hormone axis peptides class. A specification is a decision the index made; a result is a measurement. See where each threshold came from.
| Parameter | Method | Result | Unit | Index spec | |
|---|---|---|---|---|---|
| Purity | RP-HPLC, 25 min gradient, 214 nm | 99.65 | % area | ≥ 99.0 | PASS |
| Total impurities | RP-HPLC, sum of reported peaks | 0.35 | % area | ≤ 1.0 | PASS |
| Largest single impurity | RP-HPLC — [D-Trp]-epimer | 0.20 | % area | ≤ 1.00 | PASS |
| Identity | not ordered on this submission | not determined | — | required for VERIFIED status | NOT TESTED |
| Total peptide content | by difference from the gravimetric mass balance | 88.24 | %w/w | — | NOT TESTED |
| Target-compound content | total peptide content × purity | 87.93 | %w/w | — | NOT TESTED |
| Gross fill (as weighed) | five-place balance, under nitrogen | 2.42 | mg | 2 mg declared | NOT TESTED |
| Recovered target peptide | gross fill × target content | 2.128 | mg | 2 mg claim | NOT TESTED |
| Recovery against label claim | recovered ÷ claim | 106.4 | % | 90.0 – 110.0 | PASS |
| Water content | Karl Fischer, coulometric, duplicate | 4.59 | % | ≤ 9.0 | PASS |
| Counter-ion (acetate) | anion-exchange ion chromatography | 6.85 | % | ≤ 12.0 | PASS |
| Residual solvent + inorganic residue | estimated — see /methods/residual-solvents-q3c/ | 0.32 | % | — | NOT TESTED |
| Endotoxin | not ordered on this submission | not determined | — | ≤ 5.0 | NOT TESTED |
| Sterility | not ordered on this submission | not determined | — | no growth | NOT TESTED |
| Appearance | visual, diffuse light, black and white background | White lyophilised cake, intact | — | white to off-white intact cake | PASS |
| Reconstitution clarity | reconstituted per submitter procedure | Clear with a single visible fibre | — | clear, no visible particulates | FAIL |
| pH (reconstituted, 1 mg/mL) | potentiometric, two-point calibration | 4.31 | — | 2.5 – 8.0 | PASS |
| Retention time (observed) | RP-HPLC, 25 min gradient | 7.24 | min | 7.15 ± 0.25 (normalised) | PASS |
| Peak asymmetry (10 % height) | Ph. Eur. 2.2.46 | 1.05 | — | 0.80 – 1.50 | PASS |
| Plate count, main peak | N = 5.54 (t/w½)² | 58,309 | — | ≥ 20,000 | PASS |
| Resolution to nearest impurity | vs [D-Trp]-epimer | 0.81 | — | no index criterion | REPORTED |
Chromatogram and peak integration
The figure is drawn from the table. It is not an independent illustration — if a number in the table changed, the trace would change with it.
| # | Peak | RT | Area (µV·s) | % area | Δ mass (Da) |
|---|---|---|---|---|---|
| 1 | GHRP-6 — main peak | 7.24 | 4,843,299 | 99.65 | — |
| 2 | [D-Trp]-epimer | 7.14 | 9,721 | 0.20 | 0.000 |
| 3 | oxidised Trp (+16 Da) | 6.96 | 3,888 | 0.08 | +15.995 |
| 4 | bis-oxidised Trp (+32 Da) | 6.76 | 1,944 | 0.04 | +31.990 |
| 5 | des-Lys (−128 Da) | 7.06 | 1,458 | 0.03 | -128.095 |
| Closure check — purity + Σ impurities | 100.00 | CLOSES | |||
Reporting threshold 0.05 % area. Peaks below it are not reported and are therefore excluded from the total, which overstates purity by their sum — see peak integration.
Gravimetric mass balance
Water, counter-ion, residual and total peptide content are exhaustive and mutually exclusive categories. They must account for 100 % of the cake mass. The index closes this to within 0.02 pp and the build asserts it.
| Component | Determination | %w/w of cake |
|---|---|---|
| Water | Karl Fischer | 4.59 |
| Counter-ion (acetate) | ion chromatography | 6.85 |
| Residual solvent + inorganic residue | estimated | 0.32 |
| Total peptide content | by difference | 88.24 |
| Total | 100.00 CLOSES | |
Supplier certificate, as declared
The supplier's own figures for this lot, beside the independent measurement. Divergence is assessed against the batch median, not against this single report — see rule AX-R05.
| Figure | Supplier COA | This report | Index note |
|---|---|---|---|
| Purity (% area) | 99.28 | 99.65 | divergence -0.37 pp vs batch median |
| Total impurities (% area) | 0.72 | 0.35 | |
| Largest single impurity (% area) | 0.44 | 0.20 | |
| Water (%) | 2.5 | 4.59 | |
| Counter-ion (%) | 6.4 | 6.85 | |
| Peptide content (%w/w) | 90.5 | 88.24 | |
| Endotoxin (EU/mg) | not stated | not determined | |
| Method stated on certificate | YES | — | column, gradient and wavelength given |
Provenance and caveats
Where a sample came from changes the weight of the evidence. The index treats it as a first-class field.
- Sample provenance
- Buyer-sourced
- Evidentiary weight
- Strongest available evidence in this index.
- Chain of custody
- Retail purchase → submitter (−20 °C, 15 d) → laboratory (courier, dry ice, 9 d) → assay.
- Assay date
- 11 Oct 2024
- Submitted to the index
- 15 Oct 2024
- Laboratory
- Medutest, Ljubljana, Slovenia
- Method basis
- 25 min gradient · unit-resolution MS
- Verification status
- PURITY ONLY
Annotations 2
Signed technical comments from index contributors. Not a discussion forum — annotations question or contextualise the result, and the data team replies where a reply is warranted.
Related records
Same batch — lot PPG-2405-W6859 n=7
| Report | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|
| AX-2024-005363 | PPG-2405-W6859 | Janoshik | 2024-Q4 | 99.63 | 4.97 | 105.1 | Buyer-sourced | 0 | PASS |
| AX-2024-005365 | PPG-2405-W6859 | VendorInvestigate | 2024-Q4 | 99.93 | 4.57 | — | Buyer-sourced | 0 | PASS |
| AX-2024-005366 | PPG-2405-W6859 | Janoshik | 2024-Q4 | 99.71 | 4.56 | — | Buyer-sourced | 0 | PASS |
| AX-2025-021182 | PPG-2405-W6859 | PeptideMeter | 2024-Q4 | 99.93 | 4.32 | 88.6 | Laboratory-retained | 1 | MARGINAL |
| AX-2025-021183 | PPG-2405-W6859 | PeptideMeter | 2024-Q4 | 99.52 | 4.58 | 99.0 | Buyer-sourced | 0 | PASS |
| AX-2024-005367 | PPG-2405-W6859 | Medutest | 2024-Q4 | 99.56 | 4.45 | — | Buyer-sourced | 0 | PASS |
Cross-sections
- All GHRP-6 records n=206
- All PPG records n=213
- All Medutest records n=934
- All 2024-Q4 records n=416
- GHRP-6 by supplier
- GHRP-6 impurity profile
| Report | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042012 | AMB | AMB-2603-S5667 | Janoshik | 2026-Q3 | 99.37 | 5.90 | 88.8 | Laboratory-retained | 1 | MARGINAL |
| AX-2026-042528 | HJ | HJ-2603-R5329 | VendorInvestigate | 2026-Q3 | 98.69 | 1.87 | 95.8 | Buyer-sourced | 0 | FAIL |
| AX-2026-042015 | AMB | AMB-2603-S5667 | Janoshik | 2026-Q3 | 99.54 | 6.44 | 97.1 | Buyer-sourced | 0 | PASS |
| AX-2026-042526 | HJ | HJ-2603-R5329 | Medutest | 2026-Q3 | 99.37 | 3.06 | — | Laboratory-retained | 0 | PASS |
| AX-2026-042527 | HJ | HJ-2603-R5329 | VendorInvestigate | 2026-Q3 | 99.21 | 2.77 | 93.2 | Buyer-sourced | 0 | PASS |
| AX-2026-042525 | HJ | HJ-2603-R5329 | Janoshik | 2026-Q3 | 99.52 | 3.24 | 92.0 | Buyer-sourced | 0 | PASS |
| AX-2026-042013 | AMB | AMB-2603-S5667 | Kestrel | 2026-Q3 | 99.93 | 5.75 | — | Buyer-sourced | 0 | PASS |
| AX-2026-042017 | AMB | AMB-2603-S5667 | Medutest | 2026-Q3 | 99.76 | 6.42 | 97.4 | Buyer-sourced | 0 | PASS |
| Report | Compound | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043598 | Tesamorelin | PPG-2608-A6835 | Kestrel | 2026-Q3 | 98.91 | 2.56 | 100.3 | Buyer-sourced | 1 | FAIL |
| AX-2026-043597 | Tesamorelin | PPG-2608-A6835 | Janoshik | 2026-Q3 | 98.54 | 1.15 | — | Buyer-sourced | 0 | PASS |
| AX-2026-043596 | Tesamorelin | PPG-2608-A6835 | PeptideMeter | 2026-Q3 | 98.74 | 1.83 | 105.1 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043605 | Retatrutide | PPG-2604-X7060 | Janoshik | 2026-Q2 | 98.17 | 4.29 | 99.7 | Buyer-sourced | 0 | PASS |
| AX-2026-043601 | Retatrutide | PPG-2604-X7060 | Janoshik | 2026-Q2 | 98.28 | 3.96 | 95.3 | Buyer-sourced | 0 | PASS |
| AX-2026-043668 | AOD-9604 | PPG-2602-W8018 | PeptideMeter | 2026-Q2 | 99.47 | 3.06 | — | Buyer-sourced | 0 | PASS |
| AX-2026-043670 | AOD-9604 | PPG-2602-W8018 | PeptideMeter | 2026-Q2 | 99.56 | 2.71 | 104.5 | Buyer-sourced | 0 | PASS |
| AX-2026-043630 | CJC-1295 (no DAC) | PPG-2512-D7211 | Janoshik | 2026-Q2 | 99.66 | 5.11 | 92.5 | Buyer-sourced | 0 | PASS |